Tag: Nasdaq:BIOA

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsNasdaq:BIOA

Queen Máxima of the Netherlands Appointed Chair of Global Finance & Technology Network’s International Advisory Board

Volta Labs Expands Presence in the Nordic Region with Callisto Placement at Norway’s Norwegian Sequencing Centre, University of Oslo

Planisware accelerates its development in Asia and announces the opening of an office in Seoul

Tag: Nasdaq:BIOA

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us